Disclosure under Regulation 74(5) of SEBI (DP) Regulations is submitted.
DRAGARWQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Agarwal's Eye Hospital submitted a compliance certificate to BSE confirming that share dematerialisation and rematerialisation operations for Q1 2026 (January to March) were handled as per SEBI regulations. The certificate from the company's Registrar and Transfer Agent, Integrated Registry Management Services, confirms that shares were properly listed, mutilated certificates cancelled within 15 days, and all details were furnished to the stock exchanges. This is a routine quarterly regulatory filing required under SEBI Depositories and Participants Regulations.
No direct impact on shareholders or stock price. This is a standard procedural compliance filing confirming proper handling of share registry operations during the quarter.